The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: Results of a 25-year follow-up study
Open accessAbstract
AIM: IBD is a systemic disease associated with a large number of extraintestinal manifestations (EIMs). Our aim was to determine the prevalence of EIMs in a large IBD cohort in Veszprem Province in a 25-year follow-up study. METHODS: Eight hundred and seventy-three IBD patients were enrolled (ulcerative colitis/UC/: 619, m/f: 317/302, mean age at presentation: 38.3 years, average disease duration: 11.2 years; Crohn's disease/CD/: 254, m/f: 125/129, mean age at presentation: 32.5 years, average disease duration: 9.2 years). Intestinal, extraintestinal signs and laboratory tests were monitored regularly. Any alteration suggesting an EIMs was investigated by a specialist. RESULTS: A total of 21.3% of patients with IBD had EIM (UC: 15.0%, CD: 36.6%). Age at presentation did not affect the likelihood of EIM. Prevalence of EIMs was higher in women and in CD, ocular complications and primary sclerosing cholangitis (PSC) were more frequent in UC. In UC there was an increased tendency of EIM in patients with a more extensive disease. Joint complications were more frequent in CD (22.4% vs UC 10.2%, P<0.01). In UC positive family history increased the risk of joint complications (OR:3.63). In CD the frequency of type-1 peripheral arthritis was increased in patients with penetrating disease (P=0.028). PSC was present in 1.6% in UC and 0.8% in CD. Dermatological complications were present in 3.8% in UC and 10.2% in CD, the rate of ocular complications was around 3% in both diseases. Rare complications were glomerulonephritis, autoimmune hemolytic anaemia and celiac disease. CONCLUSION: Prevalence of EIM in Hungarian IBD patients is in concordance with data from Western countries. The high number of EIM supports a role for complex follow-up in these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Podolsky, D. K. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020831 · Cited by 3,159
Ford Alexander, C., Paul, M., Hanauer Steven, B., 谭蓓, & Dong, W. Z. (2001) · Cited by 3,020
Inflammatory bowel disease: Etiology and pathogenesis
Fiocchi, C. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70381-6 · Cited by 2,059
GREENSTEIN, A. J., JANOWITZ, H. D., & SACHAR, D. B. (1976) · Medicine · doi:10.1097/00005792-197609000-00004 · Cited by 1,130
Extraintestinal Manifestations of Inflammatory Bowel Disease
Vavricka, S. R., Schoepfer, A., Scharl, M., Lakatos, P. L., Navarini, A., & Rogler, G. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000392 · Cited by 909
The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study
Bernstein, C. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02319-x · Cited by 815
Orchard, T. R., Wordsworth, B. P., & Jewell, D. P. (1998) · Gut · doi:10.1136/gut.42.3.387 · Cited by 549
Rankin, G. B., Watts, H. D., Melnyk, C. S., & Kelley, M. L. (1979) · Gastroenterology · doi:10.1016/0016-5085(79)90391-3 · Cited by 533
Long-term follow-up of patients with Crohn's disease
Farmer, R. G., Whelan, G., & Fazio, V. W. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90006-x · Cited by 440
Prevalence of Primary Sclerosing Cholangitis in Patients With Ulcerative Colitis
Olsson, R., Danielsson, Å., Järnerot, G., Lindström, E., Lööf, L., Rolny, P., Rydén, B.-O., Tysk, C., & Wallerstedt, S. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)70019-t · Cited by 426
Long-term follow-up of patients with Crohn's disease
Ricketts, R. R. (1986) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(86)80458-4 · Cited by 395
Inflammatory bowel disease is not associated with an increased risk of lymphoma
Lewis, J. D., Bilker, W. B., Brensinger, C., Deren, J. J., Vaughn, D. J., & Strom, B. L. (2001) · Gastroenterology · doi:10.1053/gast.2001.28703 · Cited by 296
Genetic markers may predict disease behavior in patients with ulcerative colitis
Roussomoustakaki, M., Satsangi, J., Welsh, K., Louis, E., Fanning, G., Targan, S., Landers, C., & Jewell, D. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9178675 · Cited by 275
Inflammatory Bowel Disease Is Not Associated With An Increased Risk Of Lymphoma
&NA; (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200112000-00025 · Cited by 250
Azathioprine for maintenance of remission in Crohn's disease: Benefits outweigh the risk of lymphoma
Lewis, J. D., Schwartz, J. S., & Lichtenstein, G. R. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70353-2 · Cited by 242
Clinical patterns of familial inflammatory bowel disease.
Satsangi, J., Grootscholten, C., Holt, H., & Jewell, D. P. (1996) · Gut · doi:10.1136/gut.38.5.738 · Cited by 238
Farrell, R. J., & Peppercorn, M. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07499-8 · Cited by 236
Platelets circulate in an activated state in inflammatory bowel disease
Collins, C. E., Cahill, M. R., Newland, A. C., & Rampton, D. S. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90741-2 · Cited by 227
Extracolonic diagnoses in ulcerative colitis: an epidemiological study.
Monsén, U., Sörstad, J., Hellers, G., & Johansson, C. (1990) · PubMed · Cited by 204
An analysis of 10218 ulcerative colitis cases in China
Jiang, X.-L. (2002) · World Journal of Gastroenterology · doi:10.3748/wjg.v8.i1.158 · Cited by 177
Renal and Urologic Complications of Inflammatory Bowel Disease
Pardi, D. S., Tremaine, W. J., Sandborn, W. J., & McCarthy, J. T. (1998) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.156_b.x · Cited by 154
Extraintestinal Manifestations of Idiopathic Inflammatory Bowel Disease
Danzi, J. T. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380020041008 · Cited by 146
Risk of colorectal neoplasia in patients with primary sclerosing cholangitis
Loftus, E. V., Sandborn, W., Tremaine, W., Mahoney, D., Zinsmeister, A., Offord, K., & Melton, L. J. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8566590 · Cited by 136
The Liver in Ulcerative Colitis
Perrett, A. D., Higgins, G. S., Johnston, H. H., Massarella, G. R., Truelove, S. C., & Wright, R. (1971) · QJM · doi:10.1093/oxfordjournals.qjmed.a067266 · Cited by 123
Inflammatory Bowel Disease Promotes Venous Thrombosis Earlier in Life
Grip, O., Svensson, P. J., & Lindgren, S. (2000) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655200750023589 · Cited by 122
Liebman, H. A., Kashani, N., Sutherland, D., McGehee, W., & Kam, L. Y. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70253-7 · Cited by 101
Perrett, A. D., Higgins, G. S., Johnston, H. H., Massarella, G. R., Truelove, S. C., & Wright, R. (1971) · QJM · doi:10.1093/oxfordjournals.qjmed.a067265 · Cited by 94
Guédon, C., Cam-Duche, V. L., Lalaude, O., Ménard, J.-F., Lerebours, E., & Borg, J. Y. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03797.x · Cited by 87
Pyoderma Gangrenosum Associated with Crohn Disease: Effect of TNF- α Blockade with Infliximab
Ljung, T., Staun, M., Grove, O., FAUSA, O., Vatn, M. H., & Hellström, P. M. (2002) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655202320378338 · Cited by 83
Management of Primary Sclerosing Cholangitis
Lee, Y., & Kaplan, M. M. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05585.x · Cited by 71
Broomé, U., Glaumann, H., & Hultcrantz, R. (1990) · Gut · doi:10.1136/gut.31.4.468 · Cited by 46
Heikius, B., Niemelä, S., Lehtola, J., Karttunen, T. J., & Lahde, S. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709000186 · Cited by 45
Immunology of inflammatory bowel diseases.
Lakatos, L. (2000) · PubMed · Cited by 31
Self-citation
Cited by
The burden of inflammatory bowel disease in Europe
Burisch, J., Jess, T., Martinato, M., & Lakatos, P. L. (2013) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2013.01.010 · Cited by 961
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma
Bowlus, C. L., Arrivé, L., Bergquist, A., Deneau, M., Forman, L., Ilyas, S. I., Lunsford, K. E., Martinez, M., Sapisochin, G., Shroff, R., et al. (2023) · Hepatology · doi:10.1002/hep.32771 · Cited by 428
The Burden of Inflammatory Bowel Disease in Europe in 2020
Zhao, M., Gönczi, L., Lakatos, P. L., & Burisch, J. (2021) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjab029 · Cited by 426
Extraintestinal manifestations and complications in IBD
Ott, C., & Schölmerich, J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.117 · Cited by 351
Inflammatory bowel disease in Asia: A systematic review
Prideaux, L., Kamm, M. A., De Cruz, P. P., Chan, F. K. L., & Ng, S. C. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07150.x · Cited by 345
Metadata
- Authors
- Lakatos, L.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2003
- Volume
- 9
- Issue
- 10
- Pages
- 2300
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W1593140847
- Cited by
- 308
- References
- 33
- FWCI
- 5.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.